expressor software has announced an update to its enterprise data integration platform, which features enhancements in performance and reusable data mappings. expressor 3.0 is a design, development ...
Expressor Software, a provider of data integration software, has announced the general availability of Expressor 3.3, the third enhancement release of the Expressor Data Integration Platform since the ...
expressor software and BIReady Sign Technology Partnership to Jointly Deliver Flexible, Cost-Effective Data Warehouse Solution Based on Shared Business Metadata Foundation Combination of expressor ...
Pivotal studies testing new options in previously untreated double-expressor (MYC/BCL2) diffuse large B-cell lymphoma (DLBCL) yielded differing results, according to findings presented at the recent ...
LABVANTAGE Labvantage Becomes Premier Solution Provider for expressor Software to Provide Comprehensive Data Integration Solutions to Laboratories expressor software today announced an alliance with ...
Brukinsa combined with R-CHOP is effective for DEL, with high response rates and acceptable safety. DEL is defined by MYC and BCL2 protein expression without gene rearrangements. Progression-free and ...
So, should patients with relapsed double-hit and double-expressor lymphoma be offered autoHCT? What are the alternatives to autoHCT? There are, unfortunately, no clear answers to these questions, ...
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan DEL and DHL are both associated with inferior outcomes ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Expressor Software Corp., a Burlington-based data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results